What this study is
The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D):
- The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies.
- The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics.
- The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics.
Participants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.
What's being tested
- Continuous Glucose Monitoring Academy
Intervention · BEHAVIORAL
Educational materials as well as online sessions with diabetes educators.
- Standard Education
Intervention · BEHAVIORAL
Standard of care receives general education about diabetes.
Study details
- Official title
- Randomized Control Trial Evaluating the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes
- Sponsor
- Children's Hospital Los Angeles
- Conditions
- Type 2 Diabetes
- Enrolling
- 60 people
- Starts
- 2025-06-23
- Est. completion
- 2026-12-30
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 8 Years – 21 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Current age of 8-21 years;
- T2D diagnosis;
- Able to speak, read, and write English or Spanish
You can't join if
- A. Known history of medical adhesive allergies;
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openChildren's Hospital Los Angeles
Los Angeles, California, United States
- Natalia Garban · Contactngarban@chla.usc.edu
- Rebecca Barber, PhD, RN · Principal investigator
Recruiting
Study team
Sponsor
Children's Hospital Los Angeles
Study ID CHLA-24-00199
Principal investigator
Rebecca Barber, PhD, RN
Children's Hospital Los Angeles
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.